Experimentation Matters - Unlocking the potential of new technologies for
innovation
Book Author - Stefan H. Thomke
Published by -
HBS Press
Book Review by - Vivek
Gupta Faculty Member,ICMR Case Studies and Management Resources
About the Author
Stefan H. Thomke is an associate
professor of technology and operations management at Harvard Business School,
where he has been a faculty member since 1995. His research and writing focus on
the management of technological innovation, product development and
experimentation strategies. Thomke has authored or co-authored more than three
dozen academic papers, articles, cases and notes, which have been published in
leading journals such as the California Management Review, Harvard Business
Review, Journal of Product Innovation Management Science, Research Policy,
Scientific American, and Strategic Management Journal. Thomke holds a Ph.D. in
electrical engineering and management from the Massachusetts Institute of
Technology (MIT).
Abstract of Book Review
Computer based simulations & modeling
and field programmable technology has significantly improved the experimentation
process. The combination of technology with the right experimentation process
has enabled various companies in providing world-class products. There are
several examples of product innovations in the automotive, pharmaceutical and
software industry, all due to new technologies and the spirit of experimentation
of companies
Book Snapshot:
The book discusses the various new technologies that have shaped the
experimentation process in today's economy. It explains why experimentation
matters and the key technology drivers that have contributed to these
experimentations. The book describes the learning curve that various companies
like Elli Lily, BMW and Microsoft have undergone during their experimentation
process. It also describes about the strategies of how today's managers should
deal with the experimentation which must lead to innovation.
|
|
Introduction:
Any product development exercise goes through a series of processes starting
from idea generation, concept testing, experimentation and then finally the
market testing of the product. Any product before reaching to the final
consumers goes through a number of experiments and each experiment makes the
product more productive and effective with the implementation of the lessons
learnt from the last experiment. Experimentation is one of the most important
part of the product development process that leads to innovation. Though
experimentation is an integral part of innovation, every experimentation process
may not lead to innovation. This depends upon the scope of the experimentation.
The old experimentation process, which involved intensive paper work, developing
and testing of hypothesis, has changed significantly with the introduction of
new technologies. Simulation computer modeling and combinatorial technologies
have made the experimentation process simple and has provided a wide scope to
the companies to have more and more experimentation in different dimensions.
Today, most of the companies do experimentation virtually. Let us go through
some of the points, which form the basis of experimentation in today's economy
and deal with issues including technology advancement and how organizations are
encoding experimentation to their core business processes.
The Technology Affect
The marginal cost of experimentation
has come down drastically with the use of advanced technologies. Let us briefly
understand these technologies and how companies are using them for their
advantage:
Computer Simulation and Modeling: The first prototype computer in 1945 and Monte
Carlo methods for numerical simulations are the basis for computer based
simulations and modeling. Growth and technological advancement in the
semiconductor industry has also made simulation techniques quick. Sequencing
analysis of the human genome, design of modern airplanes and automobiles to
understand the flow of fluid has been made possible through the computer based
simulation and modeling. Following are the major changes brought by this
technology:
-
Ability to experiment fast at less
cost: Imagine how much money it will involve for an organization to go for crash
simulation if they do not have the facility for computer based simulation.
-
Opportunity to learn more: More
experimentation leads to more knowledge and where there is a huge knowledge base
there are better chances of coming up with innovative products.
-
Ability to produce effective results:
Companies are able to produce better results due to the help of this technology,
satisfying more customers with their products. This has resulted in improved
brand value for the organization and better image among the customers.
Though there are several benefits of
computer based simulation and modeling, there are some limitations as well. In
some cases, law agencies do not agree with the computer based simulation data
and companies have to conduct simulation physically. For example, the National
Highway Safety Traffic Administration (NHSTA) in the US requires data from
traditional simulation test. In some cases, the technology needs to be more
advanced. For example, in the case of rollover accidents, computer simulations
cannot work, as it requires tremendous computational power.
Combinatorial Technologies: These technologies have significantly improved the
ability to design, implement and analyze experiments. This effect can be seen in
the drug industry where the whole process of experimentation has been
revolutionized. The experimentation process for new drug discovery has changed
significantly. Earlier, where the drug companies could develop one prototype at
a time can now develop numerous prototype variations. New technologies developed
by Massachusetts Institute of Technology (MIT) like sterolithography helps in
developing three dimensional plastic objects from CAD drawings which earlier
involved significant time and costs. Other major benefits reaped due to the
advancement in the technology includes:
-
Major improvement in the drug
discovery experimentation process.
-
Strategic alliance by many drug
companies to share the available database and knowledge to develop new products.
-
Most of the companies have moved to
the web based systems to share information between their R&D labs across
different geographical locations.
More>>
Millennium Pharmaceuticals (MP)
Bank of America
2004, ICMR Case Studies and Management Resources. All rights reserved. No part of this publication may be
reproduced, stored in a retrieval system, used in a spreadsheet, or transmitted
in any form or by any means - electronic or mechanical, without permission.
|